The patients with T2DM who failed to achieve target HbA1c level with previous premixed insulin with or without OAD (glimepiride plus metformin) showed that switching to a combination therapy of Gla-100 and glimepiride improved glycemic control along with high patient tolerability [6]. Here, INS is linked to type 2 diabetes mellitus.